• If you are wondering whether Concentrix at around US$26.78 is a bargain or a value trap, the key lies in understanding how its current price lines up with different valuation checks.
• The stock has seen a 9.5% decline over the last 7 days, sits roughly flat over 30 days with a 1.1% gain, and is still showing heavier falls of 35.0% year to date and 45.3% over the past year.
• Those moves come after a much longer slide, with 3 year returns of 70.1% and 5 year returns of 81.6%. This keeps many investors focused on whether expectations have become too low or risks are still being reassessed. This backdrop makes it especially important to test the share price against a structured valuation framework rather than relying on the headline performance alone.
• On Simply Wall St's 6 point valuation check, Concentrix currently scores 5 out of 6. The rest of this article will compare what different valuation methods say about that score and then finish with a more complete way to think about the stock's value.

Find out why Concentrix's -45.3% return over the last year is lagging behind its peers.

Approach 1: Concentrix Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company could be worth today by projecting its future cash flows and then discounting those back to a single present value.

For Concentrix, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flows in $. The latest twelve month free cash flow is about $479.8 million. Simply Wall St then applies analysts' near term expectations and extends those further out, with ten year projections that reach $616.2 million of free cash flow in 2035. Beyond the explicit analyst window, those projections are extrapolated using modest growth assumptions.

Bringing all those future cash flows back to today, the model arrives at an estimated intrinsic value of about $84.77 per share. Against a current share price around $26.78, this implies the stock is 68.4% undervalued according to this DCF output.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Concentrix is undervalued by 68.4%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Concentrix.

Approach 2: Concentrix Price vs Sales

For many profitable service companies, revenue is a useful anchor for valuation because it tends to be less volatile than earnings and ties closely to the scale of the business. That is why the preferred multiple here is Price to Sales, or P/S.

What counts as a fair P/S ratio depends on what the market expects for growth and how risky the cash flows appear. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher uncertainty usually point to a lower one.

Concentrix currently trades on a P/S of 0.16x. That sits well below the Professional Services industry average P/S of 1.14x and below the peer group average of 1.78x. Simply Wall St’s Fair Ratio for Concentrix is 0.88x, which is a proprietary estimate of the P/S the company might trade on given its earnings growth profile, margins, industry, market cap and risk characteristics.

This Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for business quality and risk, instead of assuming all companies deserve the same multiple. With Concentrix on 0.16x versus a Fair Ratio of 0.88x, the multiple based view indicates that the shares appear undervalued on this measure.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 17 top founder-led companies.

Upgrade Your Decision Making: Choose your Concentrix Narrative

Earlier the idea of a better way to understand valuation was raised, and that is where Narratives come in. They give you a simple way to attach your own story about Concentrix to the numbers by linking assumptions for future revenue, earnings, margins and fair value to a live forecast on Simply Wall St’s Community page. You can then compare that fair value with the current price so you can judge whether the shares look expensive or cheap to you, while seeing in real time how that story updates when new earnings or news arrive. For example, you might set a higher fair value closer to US$80 if you think AI adoption, margin expansion and earnings growth could follow the more optimistic assumptions, or lean toward US$32 if you focus more on modest growth, margin pressure and balance sheet risk.

Do you think there's more to the story for Concentrix? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.